Position in SIGA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$964,236
-$1,477,423 QoQ
Shares Held
264,900
-42.0% QoQ
Ownership
0.369%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 160 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. SIGA ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in SIGA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $964,236 | 264,900 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,441,659 | 456,385 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,388,427 | 554,571 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,572,739 | 499,753 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,823,303 | 433,022 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,002,245 | 547,855 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,561,886 | 592,660 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,593,462 | 680,513 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,152,350 | 1,074,091 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,692,916 | 548,238 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,985,681 | 711,729 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,177,329 | 795,682 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,245,206 | 840,635 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,319,393 | 1,099,025 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,000,152 | 1,494,586 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,680,527 | 2,201,993 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,247,394 | 3,216,528 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,022,420 | 144,206 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,107,959 | 147,335 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $74,173 | 10,037 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $358,952 | 57,158 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $124,442 | 19,145 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $89,859 | 13,080 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||